中国中西医结合杂志2025，Vol.45Issue(10)：1157-1164,8.DOI:10.7661/j.cjim.20250912.277
基于"三医"协同治理探讨数智赋能中西医协同诊疗
Exploring Digital Intelligence Empowered Collaborative Diagnosis and Treatment between Chinese Medicine and Western Medicine Based on the Coordinated Governance of "Health Services,Health Insurance and Pharmaceuticals"
摘要
Abstract
Under the digital and intelligent empowerment,collaborative diagnosis and treatment between Chinese Medicine and Western Medicine(CDTCMWM)serves as a significant driver for promoting the inheritance and innovation of Chinese Medicine.Based on the three dimensions of "Health Services,Health Insurance and Pharmaceuticals" and from the perspective of coordinated governance,this paper elaborates and analyzes the connotation of digital intelligence empowered CDTCMWM,systematically identifies existing issues:the integration and application of clinical data from collaboration of Chinese and Western medicine still face impediments;shortage of talent in integrated Chinese and Western medicine with digital and intelligent literacy;the quality of medical records and its data statistics requires improvement;the adaptation mechanisms of health insurance systems for innovative medical technologies are not yet sound;the digital and intelligent development of use of Chinese and Western medicine still has limitations;obstacles persist in the digital and intelligent transformation of medical devices of Chinese Medicine,and puts forward corresponding countermeasures.In order to provide a reference for promoting the high-quality development of CDTCMWM,improving people's health,and realizing the Healthy China strategy.关键词
数智赋能/中西医协同诊疗/高质量发展/"三医"协同治理Key words
digital intelligence empowerment/collaborative diagnosis and treatment between Chinese Medicine and Western Medicine/high-quality development/coordinated governance on "Health Services,Health Insurance and Pharmaceuticals"引用本文复制引用
刘琳蔚,张秋,张舒丽,任秋实,徐靖,刘子锋..基于"三医"协同治理探讨数智赋能中西医协同诊疗[J].中国中西医结合杂志,2025,45(10):1157-1164,8.基金项目
广东省哲学社会科学规划一般项目(No.GD24CGL29) （No.GD24CGL29）
